Sanbio | Life science products and services in the BeNeLux.

Reducing matrix variability in 3D cell culture

Written by Tom Geurink | Aug 24, 2026, 12:10:13 PM

 How a defined extracellular matrix hydrogel can support more controlled organoid, spheroid and tumour model workflows.

Three-dimensional (3D) cell culture models are increasingly used to study complex biology in a more physiologically relevant environment. Organoids, spheroids and tumour models can provide valuable insights into growth, differentiation, invasion and treatment response.

As these models become more complex, reproducibility becomes even more important. One factor that is often underestimated is the extracellular matrix (ECM). In 3D cell culture, the matrix is not simply a scaffold. It helps shape the microenvironment that cells experience and can influence morphology, organisation, signalling and downstream readouts.

Literature on organoid workflows highlights that matrix composition, mechanical properties and batch consistency can all affect experimental outcomes.[1,2]

 

Why matrix consistency matters

Some commonly used 3D matrices are complex biological mixtures. While these matrices can effectively support 3D culture, their composition is often less defined and may vary between batches. For sensitive 3D models, this can introduce an unwanted experimental variable.

That variability can make it harder to answer a very practical research question:

Is the observed effect caused by the biology of the model, or by variation in the culture environment?

For research groups working with organoids, spheroids, tumour models or drug screening assays, reducing matrix-related variability can help improve confidence in experimental results. Recent reviews describe batch-to-batch variability of animal tissue-derived ECMs as one of the factors limiting reproducibility in organoid production.[3,4]

 

Introducing MatriMix (511) from Amsbio

MatriMix (511) from Amsbio is a defined ECM hydrogel for 3D cell culture. Its defined composition provides a more controlled alternative to poorly defined ECM mixtures and may help reduce matrix-related variability in sensitive 3D workflows.

The hydrogel contains collagen, laminin-511 E8 fragments and hyaluronic acid. It is supplied in a three-component format that is prepared before use and forms a gel at 37 °C. Depending on the model and application, cells can be cultured either within the gel or on top of the gel.[5]

Key features include:

  • Defined ECM composition based on collagen, laminin-511 E8 fragments and hyaluronic acid
  • Three-component format prepared before use
  • Gel formation at 37 °C
  • Use for in-gel or on-gel 3D culture
  • Relevance for organoid, spheroid and tumour model workflows
  •  

Where MatriMix may fit in your workflow

MatriMix may be especially relevant when working with:

  • Organoid cultures
  • Spheroid models
  • Tumour models
  • Complex 3D cell cultures
  • Drug screening workflows

For researchers working with complex 3D models, a more defined matrix can help reduce one source of experimental uncertainty and provide a more controlled starting point for protocol optimisation.

As with any 3D culture matrix, protocol optimisation may be needed. Cell type, seeding density, gel volume, culture format and readout method can all influence performance. Gel volume and gel height can also influence cell positioning during gelation, so the protocol should be adjusted to the vessel and application used.

 

Conclusion

In 3D cell culture, consistency is not simply convenient. It can be important for interpreting experimental results with confidence.

MatriMix (511) from Amsbio provides a defined ECM hydrogel approach for researchers looking to reduce matrix-related variability and create more controlled 3D culture conditions.

Interested in exploring whether MatriMix fits your model?

 

Need help selecting the right option for your workflow?


 

References

  1. Kuhn MR, Wolcott EA and Langer EM. Developments in gastrointestinal organoid cultures to recapitulate tissue environments. Frontiers in Bioengineering and Biotechnology. 2025;13:1521044. doi: 10.3389/fbioe.2025.1521044
  2. Heo JH, Kang D, Seo SJ and Jin Y. Engineering the extracellular matrix for organoid culture. International Journal of Stem Cells. 2022;15(1):60–69. doi: 10.15283/ijsc21190
  3. Kim D, Youn J, Kim J, Lee J, Yoon J and Kim DS. From organoid culture to manufacturing: technologies for reproducible and scalable organoid production. npj Biomedical Innovations. 2026;3:12. doi: 10.1038/s44385-025-00054-6
  4. Guo L, Li C and Gong W. Toward reproducible tumor organoid culture: focusing on primary liver cancer. Frontiers in Immunology. 2024;15:1290504. doi: 10.3389/fimmu.2024.1290504
  5. Amsbio. MatriMix (511) 3D Cell Culture Substrate – Instruction Manual. Version 2.1.